February 8, 2017
Bayer’s and Janssen R&D’s cardiac drug meets primary goals sooner then expected
Bayer’s and Janssen R&D’s drug for cardiac situations has already met its primary goals in the early third phase of testing, the companies said today, which concludes the testing.